1. Accueil
  2. Nayema Van den Houte
  3. Nayema Van den Houte

Onglets principaux

Rechercher
Limit to
Exporter 6 resultats:
Filtres: Auteur is Nayema Van den Houte
2022
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study., Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, 2022 04 28, Volume 14, Issue 5, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study, Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, Jan-05-2022, Volume 14, Issue 5, (2022)
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium : Results of the second data collection (28/09/21-23/02/22), Van den Houte, Nayema, Leclercq V, Gisle Lydia, and Van der Heyden Johan , 21/04/2022, Brussels, Belgium, p.13, (2022)
2021
The Impact of the covid-19 on satisfaction with social contacts, Van den Houte, Nayema, and Van der Heyden Johan , European Public Health conference, 20/10/21, Volume 14th edition, (2021)
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study, Leclercq, V, Van den Houte Nayema, Gisle Lydia, and Van der Heyden Johan , 25/11/2021, Brussels, Belgium, p.80, (2021)
0
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium, March 2021 - April 2022, Leclercq, V, Gisle Lydia, Van den Houte Nayema, and Van der Heyden Johan , (0)

QR code

QR code for this page URL